Quercetin |
C2C12 cells
|
Quercetin (25, 50, 75, and 100 μM) for 24 h
|
Downregulation of Bax and ROS and the reversal of the ΔΨm imbalance
|
[279] |
3T3-L1 cells
|
Quercetin (0.1–10 µM) for 24 h
|
Reduced C/EBPβ, SREBP1, and PPARγ gene expression; reduced LPL, FAS expression and triacylglycerol content.
|
[282] |
3T3-L1 senescent cells
|
Quercetin 20 μM |
Reduction of SA-β-gal activity, ROS, and inflammatory cytokines; inhibition of miR-155-5p expression; NF-κB and p65 downregulation and SIRT-1 upregulation. |
[285] |
EGCG |
3T3-L1 senescent cells |
EGCG (50 and 100 μM) |
Downregulation of PI3K/Akt/mTOR and AMPK signaling; suppression of ROS, iNOS, Cox-2, NF-κB, SASP, and p53 mediated cell cycle inhibition; suppression of anti-apoptotic protein Bcl-2 accumulation in senescent cells. |
[287] |
3T3-L1 senescent cells |
EGCG 50 μM
|
Reduced IL-6 and CDKN1a expression levels; NRF2 and SIRT3 activation.
|
[288] |
SAMP8 mice (32 weeks old) and late passage C2C12 cells |
Diet containing without or with 0.32% EGCG for 8 weeks |
Increased miRNA-486-5p expression in both aged SAMP8 mice and C2C12 cells; AKT phosphorylation stimulation and inhibition of FoxO1; MuRF1 and Atrogin-1 in vivo and in vitro; increased Myostatin expression in C2C12 cells. |
[264] |
Cells treatment with EGCG (50 μM) for 24 h. |
Ginsenoside Rg1 |
12 young men (age 21 ± 0.2 years)
|
Rg1 (5 mg) supplementations 1 h prior to a high-intensity cycling (70% VO2max)
|
Suppression of SA-β-gal activity in exercised muscle samples. |
[289] |
Curcumin |
Male C57/B6 mice (4–6 weeks old)
|
1000 mg/kg curcumin once a day for 14 days
|
Overexpression of VEGF-A and Ang-1 in EPCs and number of senescent EPCs reduced.
|
[290] |
C57BL/6J mice (8 weeks old)
|
Curcumin (0.1%) in HFD until 80 weeks old
|
Reduction of SA-β-Gal activity and MCP-1 expression; enhanced of HO-1 activity; suppression of urinary 8OHdG and superoxide production.
|
[291] |
rADSC cells |
Curcumin (1 and 5 µM) for 48 h |
Suppression of SA-ß-gal activity; increased TERT expression levels. |
[292] |
C57BL6J and C57BL10ScSn (18 months-old)
|
Curcumin (120 μg/kg) injected subcutaneously (every 6th day, for 6 months)
|
Preserved type-1 myofiber size and increased type-2A one in soleus; increased MyoD-positive satellite cells from old hindlimb muscles.
|
[293] |
Fisetin |
Progeroid mice (p16+/Luc;Ercc1−/∆); murine embryonic fibroblasts (Ercc1−/− MEFs) and human fibroblasts (IMR90)
|
Fisetin-enriched diet (500 mg/kg)
|
Reduction of SA-β-gal activity; expression of p16Ink4a, p21Cip1 and the SASP factors in vitro and in vivo in white adipose tissue. |
[294] |
Cells treatment with fisetin (1–15
μ
M) for 48 h
|
HUVEC cells
|
Fisetin (1–100 μM) for 72 h |
Induces apoptosis in senescent cells.
|
[295] |
rADSCs cells
|
Fisetin (25, 50 or 100 µM) for 24 h |
Reduction of ROS, SA-β-gal activity, and senescence-associated heterochromatin foci. |
[298] |
Resveratrol |
Male Wistar rats
|
Resveratrol (10 mg/kg, 0.1 mL/100 g) |
Reduction in gene expression of IL-6, TNF-α and increase in Creb-1 levels; reduction of activated microglia and increase in cell proliferation.
|
[303] |
Annual fish N. guentheri
|
Resveratrol-enriched diet (200 μg/g food) until 12 months old |
Inhibition of NF-κB by decreasing RelA/p65, Ac-RelA/p65 and p-IκBα levels; reduced SA-β-gal activity; SASP-associated pro-inflammatory cytokines IL-8 and TNFα and increases anti-inflammatory cytokine IL-10; increased SIRT1 expression. |
[304] |
Proanthocyanidins |
Female Zucker fa/fa rats (5 weeks old)
|
GSPE (35 mg/kg/day) for 10 weeks
|
Inhibition of iNos and IL-6 expression and increased Adiponectin levels in adipocytes. |
[307] |
Male ICR mice (6 weeks old)
|
Procyanidin B2 by gavage (25, 50, and 100 mg/kg) for 7 days
|
Decreased TNF-α, IL-1β, COX-2, and iNOS expression; inhibited the translocation of NF-κB/p65 from the cytosol to the nuclear fraction in mouse liver; inhibited CCl4-induced hepatocyte apoptosis; suppressed the upregulation of Bax expression and restored the downregulation of Bcl-xL expression.
|
[308] |
Wistar female rats (11 weeks old) |
GSPE (75 and 200 mg/kg/day)
|
Downregulated the genes Il-6 and iNos; decreased the glutathione ratio (GSSG/total glutathione). |
[309] |
Crossbreed male pigs (Landrace × Yorkshire) |
Procyanidin-enriched diet (0.01%, 0.02%, and 0.04%) for 4 weeks
|
Reduction in the levels of IL-1β, IL-6, and TNF-α at 4 h after LPS challenge.
|
[310] |
THP-1-macrophages
|
Procyanidin B2 (10 μM) for 1–4 h |
Inhibition of inflammasome activation includes the inactivation of the NF-κB/p65 nuclear expression; repression of COX2, iNOS, IL-6, IL-1β, and NO; decreases NLRP3 and caspase-1 activation. |
[311] |
Ellagic acid |
Male C57BL/6 mice (6 to 9 weeks old) |
Ellagic acid (5, 50, and 100 mg/kg P.O) for 42 days
|
Reduction of lipid peroxidation, ROS, and Sirt3 levels; increased antioxidant capacity, GSH/GSSG ratio, and mitochondrial activity. |
[313] |
Male ICR mice (8 weeks old)
|
Ellagic acid (100 mg/kg/day) for 8 weeks
|
Enhanced fiber size and weight of gastrocnemius, and grip strength; decreased Atrogin-1 and MuRF-1 expressions; increased NRF-1 and PGC-1α expressions to alleviate mitochondrial disorder; CHOP and GRP-87 levels to relieve ER stress; inhibited BAX expressions and enhanced Bcl-2 expressions to mitigate apoptosis. |
[315] |